[flash news] 2020 / 2 / 17 who discusses four new coronavirus vaccines: human trials start as early as April

Who discussed four novel coronavirus vaccines: the first human trials began in April, and more than 300 scientists and donors participated in the first International Conference on new type of coronavirus held by WHO in Geneva recently Four candidate vaccines for the new coronavirus, funded by the Alliance for innovation in epidemic prevention, were discussed "There are four vaccines that are funded in the early pre clinical phase," sumia swaminatan, who's chief scientist, told reporters She added that the first vaccine, developed by a U.S company in collaboration with the National Institutes of health, could begin human trials in April China novel coronavirus pneumonia has been released in China The latest progress in the treatment of new crown pneumonia has been released by bio pharmaceutical products After strict blood biosafety test, virus inactivation, antiviral activity test and so on, we have successfully prepared the special plasma for clinical treatment and put it into clinical treatment of severe patients Experts said that during the outbreak of SARS, there were cases in which patients recovered from SARS were transfused with plasma to severe SARS patients to achieve cure Novel coronavirus pneumonia is the most effective method for the treatment of new crown pneumonia, and it can significantly reduce the mortality of critically ill patients under the premise of lacking vaccines and special therapeutic drugs Http://digitalpaper.stdaily.com/http_ HTM? Div = - 1 the mystery of lanthanum hydride's peculiar high temperature superconductivity has been solved by an international research team composed of Japan's Material Research Institute, Northeast University, Tokyo University and Institute of physics and chemistry Through computer simulation, lanthanum hydride has been found（ Lah10 becomes a stable "quantum solid" through the quantum fluctuation of atomic nucleus in a wide range of pressure regions under the superconducting high pressure close to room temperature (- 23 ℃) The results show that high temperature superconductivity and room temperature superconductivity can be achieved at much lower pressure than expected by hydrogen rich compounds Http://digitalpaper.stdaily.com/http_ HTM? Div = - 1 Remidevir, a Gilead antiviral drug, has been successfully treated in monkeys recently According to a new study by scientists from the National Institutes of health of the United States, remidevir, a research antiviral drug from Gilead（ Remdesvir (gs-5734) successfully prevented the disease in rhesus macaque infected with mers cov The results showed that radcivir could prevent disease before infection and improve the condition of rhesus monkey after infection It is pointed out that the use of ridcivir before or after infection with mers-cov can reduce the severity of the disease, virus replication and lung injury These data indicate that radcivir is a promising antiviral drug against mers, which can be considered in clinical trials Http:// NAT Immunol: scientists at the National Center for cardiovascular research (CNIC) in Madrid, Spain, who revealed how neutrophils can prevent the immune system from getting out of control have found a "release" mechanism that can prevent the immune system from uncontrolled activities The newly discovered immune control system is located in one of the most important cell types in the immune system, neutrophils The findings, published in the journal Nature Immunology, may have a significant impact on understanding and treatment of diseases such as myocardial infarction, stroke and acute inflammation http://